| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 102 |
| 1 | PREDNISOLONE ORAL | 102 |
| 2 | PREDNISOLONE ORAL SOLUTION | 102 |
| 3 | TACROLIMUS | 73 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 71 |
| 5 | TACROLIMUS OINTMENT 0.1% | 71 |
| 6 | PREDNISONE | 58 |
| 7 | TOCILIZUMAB | 55 |
| 8 | METHOTREXATE SODIUM | 46 |
| 9 | METHOTREXATE | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPESOLIMAB | 2 | 0.0050 |
| 1 | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HCL | 1 | 0.0042 |
| 2 | FLUCYTOSINE | 5 | 0.0035 |
| 3 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 3 | 0.0029 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 24 | 0.0029 |
| 5 | STREPTOMYCIN | 3 | 0.0026 |
| 6 | CANAKINUMAB | 27 | 0.0025 |
| 7 | DIFLUPREDNATE OPHTHALMIC | 2 | 0.0023 |
| 8 | BARICITINIB | 6 | 0.0020 |
| 9 | PREDNISOLONE SODIUM PHOSPHATE | 4 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-36 Receptor Antagonist [EPC] | 2 | 0.0050 |
| 1 | Nucleoside Analog Antifungal [EPC] | 5 | 0.0035 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | Alkaloid [EPC] | 27 | 0.0010 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 12 | 0.0009 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 19 | 0.0009 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 7 | 0.0005 |
| 7 | Benzothiazole [EPC] | 1 | 0.0004 |
| 8 | Complement 5a Receptor Antagonist [EPC] | 3 | 0.0004 |
| 9 | Penem Antibacterial [EPC] | 15 | 0.0004 |